Lv4
490 积分 2024-10-31 加入
Anthranilamide (aam)-substituted diboron: palladium-catalyzed selective B(aam) transfer
2天前
已完结
Abstract 3761: HSK26784: An oral PROTAC-BTK degrader for multiple B lymphocyte derived malignancies
4个月前
已关闭
Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges
4个月前
已完结
PROTAC cell permeability and oral bioavailability: a journey into uncharted territory
4个月前
已完结
First targeted protein degrader hits the clinic
4个月前
已完结
Abstract 5236: ARV-110: An androgen receptor PROTAC degrader for prostate cancer
4个月前
已关闭
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer
4个月前
已完结
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer
4个月前
已完结
Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer
4个月前
已完结
皖公网安备34019202002308
